NCT05060380Withdrawn
Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis
Source: ClinicalTrials.gov · Last updated 1 Jul 2026
Reason given: The study was never started.
Brief summary (registry, in English)
The aim of the 2 month randomized controlled trial is to investigate the feasibility of a novel progressive muscle resistance exercise in individuals with low bone mass.
- Status (registry)
- Withdrawn
- Study type
- Interventional
- Enrollment
- 0 (actual)
- First submitted
- 28 Jul 2021
- Start date
- 1 Dec 2026
- Primary completion date
- 1 Dec 2028
- Lead sponsor
- University of Alabama at Birmingham
- Diseases
- Osteoporosis
- NCT number
- NCT05060380
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- any structured resistance training within the previous year, and
- past therapy with any drug for osteoporosis,
- any current therapy for osteoporosis except zoledronic acid,
Other illness
- uncontrolled hypertension
- renal disease,
- uncontrolled disorders of the parathyroid
- a history of cancer in the past 5 years,
- any other medical conditions which could restrict the potential participants from full participation as decided by their physician.
Lab values
- clinical or laboratory evidence of hepatic
Other
- secondary osteoporosis
- fragility fracture,
- thyroid glands,
- inability to walk independently or
Who the study is looking for
- independent ambulatory
- diagnosed with low bone mass
Age in the registry: 55 years to 70 years · Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.